575 related articles for article (PubMed ID: 12695492)
1. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
[TBL] [Abstract][Full Text] [Related]
2. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
3. Freshly isolated Valpha24+ CD4+ invariant natural killer T cells activated by alpha-galactosylceramide-pulsed B cells promote both IgG and IgE production.
Rossignol A; Barra A; Herbelin A; Preud'homme JL; Gombert JM
Clin Exp Immunol; 2007 Jun; 148(3):555-63. PubMed ID: 17362268
[TBL] [Abstract][Full Text] [Related]
4. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
5. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?
Jiang S; Game DS; Davies D; Lombardi G; Lechler RI
Eur J Immunol; 2005 Apr; 35(4):1193-200. PubMed ID: 15770696
[TBL] [Abstract][Full Text] [Related]
6. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
7. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
9. Innate immune responses support adaptive immunity: NKT cells induce B cell activation.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
Vaccine; 2003 Jun; 21 Suppl 2():S48-54. PubMed ID: 12763683
[TBL] [Abstract][Full Text] [Related]
10. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.
Hansen DS; Siomos MA; De Koning-Ward T; Buckingham L; Crabb BS; Schofield L
Eur J Immunol; 2003 Sep; 33(9):2588-98. PubMed ID: 12938235
[TBL] [Abstract][Full Text] [Related]
11. Homeostasis of V alpha 14i NKT cells.
Matsuda JL; Gapin L; Sidobre S; Kieper WC; Tan JT; Ceredig R; Surh CD; Kronenberg M
Nat Immunol; 2002 Oct; 3(10):966-74. PubMed ID: 12244311
[TBL] [Abstract][Full Text] [Related]
12. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
Amanuma R; Nakajima T; Yoshie H; Yamazaki K
J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
[TBL] [Abstract][Full Text] [Related]
13. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
[TBL] [Abstract][Full Text] [Related]
15. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
Peralbo E; Alonso C; Solana R
Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
[TBL] [Abstract][Full Text] [Related]
16. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
Miyamoto K; Miyake S; Yamamura T
Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
[TBL] [Abstract][Full Text] [Related]
17. NKT and tolerance.
Diana J; Beaudoin L; Gautron AS; Lehuen A
Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
[TBL] [Abstract][Full Text] [Related]
18. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
19. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
20. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
